Wird geladen...
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
OBJECTIVE: The European Increlex(®) Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex(®)) therapy in patients with severe primary IGF1 deficiency (SPIGFD). We present data from patients with and withou...
Gespeichert in:
| Veröffentlicht in: | Eur J Endocrinol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bioscientifica Ltd
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849377/ https://ncbi.nlm.nih.gov/pubmed/33434161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-20-0325 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|